IN VITRO DIAGNOSTICS Mergers & Acquisitions ERBA Diagnostics Mannheim GMBH ERBA Diagnostics Inc. Escalon Medical Corp. Drew Scientific Inc. JAS Diagnostics Inc. ERBA Diagnostics Inc. , which is maj
Financings During the third quarter of 2012, biopharma financings jumped to just over $3 billion, a 13% increase over the Q2 total. Heading the list was small-molecule cancer therapeutics developer